Chinese General Practice ›› 2024, Vol. 27 ›› Issue (09): 1048-1053.DOI: 10.12114/j.issn.1007-9572.2023.0330
Special Issue: 泌尿系统疾病最新文章合集
• Original Research • Previous Articles Next Articles
Received:
2023-03-15
Revised:
2023-07-25
Published:
2024-03-20
Online:
2023-12-19
Contact:
XU Chengyan
通讯作者:
许成燕
作者简介:
基金资助:
组别 | 人数 | 肾功能异常 | 尿蛋白阳性 |
---|---|---|---|
60~69岁组 | 6 901 | 129(1.87) | 834(12.09) |
70~79岁组 | 4 867 | 286(5.88) | 662(13.60) |
80~89岁组 | 1 128 | 224(19.86) | 171(15.16) |
≥90岁组 | 184 | 74(40.22) | 23(12.50) |
χ2值 | 1 059.282 | 11.454 | |
P值 | <0.001 | 0.010 |
Table 1 Results of detection rates of positive renal dysfunction and proteinuria in different age groups
组别 | 人数 | 肾功能异常 | 尿蛋白阳性 |
---|---|---|---|
60~69岁组 | 6 901 | 129(1.87) | 834(12.09) |
70~79岁组 | 4 867 | 286(5.88) | 662(13.60) |
80~89岁组 | 1 128 | 224(19.86) | 171(15.16) |
≥90岁组 | 184 | 74(40.22) | 23(12.50) |
χ2值 | 1 059.282 | 11.454 | |
P值 | <0.001 | 0.010 |
组别 | 例数 | 年龄[M(P25,P75),岁] | 性别(男/女) | 糖尿病[名(%)] | 高血压[名(%)] | BMI [M(P25,P75),kg/m2] | BUN [M(P25,P75),mmol/L] | Scr [M(P25,P75),mmol/L] |
---|---|---|---|---|---|---|---|---|
肾功能正常组 | 12 367 | 69(66,73) | 5 424/6 943 | 2 552(20.80) | 8 208(66.40) | 24.8(22.7,27.0) | 5.77(4.90,6.77) | 62.00(54.00,72.00) |
肾功能异常组 | 713 | 78(71,85) | 325/388 | 386(54.10) | 617(86.80) | 24.9(22.4,27.1) | 8.91(7.37,11.14) | 108.00(92.00,123.20) |
Z(χ2)值 | -24.747 | 0.813a | 447.652a | 127.617a | -0.524 | -34.273 | -43.025 | |
P值 | <0.001 | 0.367 | <0.001 | <0.001 | 0.600 | <0.001 | <0.001 | |
组别 | ACR [M(P25,P75),mg/g] | TC [M(P25,P75),mmol/L] | TG [M(P25,P75),mmol/L] | HDL-C [M(P25,P75),mmol/L] | LDL-C [M(P25,P75),mmol/L] | Hb [M(P25,P75),g/L] | ||
肾功能正常组 | 20(20,20) | 5.12(4.46,5.83) | 1.29(0.95,1.81) | 1.46(1.26,1.72) | 3.06(2.48,3.66) | 135(127,144) | ||
肾功能异常组 | 20(10,25) | 4.89(4.11,5.72) | 1.51(1.06,2.07) | 1.36(1.15,1.61) | 2.83(2.16,3.49) | 124(113,136) | ||
Z(χ2)值 | -2.234 | -5.243 | -6.546 | -8.159 | -6.031 | -17.999 | ||
P值 | 0.025 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 2 Comparison of general information and laboratory examination data between the abnormal renal function group and normal renal function group
组别 | 例数 | 年龄[M(P25,P75),岁] | 性别(男/女) | 糖尿病[名(%)] | 高血压[名(%)] | BMI [M(P25,P75),kg/m2] | BUN [M(P25,P75),mmol/L] | Scr [M(P25,P75),mmol/L] |
---|---|---|---|---|---|---|---|---|
肾功能正常组 | 12 367 | 69(66,73) | 5 424/6 943 | 2 552(20.80) | 8 208(66.40) | 24.8(22.7,27.0) | 5.77(4.90,6.77) | 62.00(54.00,72.00) |
肾功能异常组 | 713 | 78(71,85) | 325/388 | 386(54.10) | 617(86.80) | 24.9(22.4,27.1) | 8.91(7.37,11.14) | 108.00(92.00,123.20) |
Z(χ2)值 | -24.747 | 0.813a | 447.652a | 127.617a | -0.524 | -34.273 | -43.025 | |
P值 | <0.001 | 0.367 | <0.001 | <0.001 | 0.600 | <0.001 | <0.001 | |
组别 | ACR [M(P25,P75),mg/g] | TC [M(P25,P75),mmol/L] | TG [M(P25,P75),mmol/L] | HDL-C [M(P25,P75),mmol/L] | LDL-C [M(P25,P75),mmol/L] | Hb [M(P25,P75),g/L] | ||
肾功能正常组 | 20(20,20) | 5.12(4.46,5.83) | 1.29(0.95,1.81) | 1.46(1.26,1.72) | 3.06(2.48,3.66) | 135(127,144) | ||
肾功能异常组 | 20(10,25) | 4.89(4.11,5.72) | 1.51(1.06,2.07) | 1.36(1.15,1.61) | 2.83(2.16,3.49) | 124(113,136) | ||
Z(χ2)值 | -2.234 | -5.243 | -6.546 | -8.159 | -6.031 | -17.999 | ||
P值 | 0.025 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 人数 | 年龄[M(P25,P75),岁] | 性别(男/女) | 糖尿病[名(%)] | 高血压[名(%)] | BMI [M(P25,P75),kg/m2] | BUN [M(P25,P75),mmol/L] |
---|---|---|---|---|---|---|---|
非蛋白尿组 | 11 390 | 69(66,74) | 4 904/6 486 | 2 467(21.80) | 7 690(67.51) | 24.8(22.7,27.0) | 5.82(4.93,6.88) |
蛋白尿组 | 1 690 | 70(66,74) | 845/845 | 471(28.00) | 1 135(67.16) | 25.2(23.0,27.4) | 6.14(5.14,7.31) |
Z(χ2)值 | -2.735 | 28.812a | 32.789a | 0.085a | 22.745b | -7.079 | |
P值 | <0.001 | <0.001 | <0.001 | 0.771 | <0.001 | <0.001 | |
组别 | Scr [M(P25,P75),mmol/L] | TC [M(P25,P75),mmol/L] | TG [M(P25,P75),mmol/L] | HDL-C [M(P25,P75),mmol/L] | LDL-C [M(P25,P75),mmol/L] | Hb [M(P25,P75),g/L] | |
非蛋白尿组 | 63.00(54.00,73.40) | 5.12(4.46,5.83) | 1.30(0.95,1.81) | 1.47(1.26,1.72) | 3.06(2.48,3.66) | 135(127,144) | |
蛋白尿组 | 66.00(55.98,79.00) | 5.03(4.35,5.78) | 1.35(0.99,1.91) | 1.41(1.21,1.66) | 2.98(2.39,3.60) | 135(126,144) | |
Z(χ2)值 | -7.407 | -3.249 | -3.425 | -6.054 | -2.902 | -0.563 | |
P值 | <0.001 | 0.001 | 0.001 | <0.001 | 0.004 | 0.573 |
Table 3 Comparison of general data and laboratory examination data between the proteinuria group and non-proteinuria group
组别 | 人数 | 年龄[M(P25,P75),岁] | 性别(男/女) | 糖尿病[名(%)] | 高血压[名(%)] | BMI [M(P25,P75),kg/m2] | BUN [M(P25,P75),mmol/L] |
---|---|---|---|---|---|---|---|
非蛋白尿组 | 11 390 | 69(66,74) | 4 904/6 486 | 2 467(21.80) | 7 690(67.51) | 24.8(22.7,27.0) | 5.82(4.93,6.88) |
蛋白尿组 | 1 690 | 70(66,74) | 845/845 | 471(28.00) | 1 135(67.16) | 25.2(23.0,27.4) | 6.14(5.14,7.31) |
Z(χ2)值 | -2.735 | 28.812a | 32.789a | 0.085a | 22.745b | -7.079 | |
P值 | <0.001 | <0.001 | <0.001 | 0.771 | <0.001 | <0.001 | |
组别 | Scr [M(P25,P75),mmol/L] | TC [M(P25,P75),mmol/L] | TG [M(P25,P75),mmol/L] | HDL-C [M(P25,P75),mmol/L] | LDL-C [M(P25,P75),mmol/L] | Hb [M(P25,P75),g/L] | |
非蛋白尿组 | 63.00(54.00,73.40) | 5.12(4.46,5.83) | 1.30(0.95,1.81) | 1.47(1.26,1.72) | 3.06(2.48,3.66) | 135(127,144) | |
蛋白尿组 | 66.00(55.98,79.00) | 5.03(4.35,5.78) | 1.35(0.99,1.91) | 1.41(1.21,1.66) | 2.98(2.39,3.60) | 135(126,144) | |
Z(χ2)值 | -7.407 | -3.249 | -3.425 | -6.054 | -2.902 | -0.563 | |
P值 | <0.001 | 0.001 | 0.001 | <0.001 | 0.004 | 0.573 |
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
高血压 | 1.212 | 0.120 | 102.277 | <0.001 | 3.361(2.657~4.251) |
糖尿病 | 1.423 | 0.088 | 264.184 | <0.001 | 4.151(3.496~4.28) |
高TG血症 | 0.560 | 0.110 | 25.754 | <0.001 | 1.751(1.410~2.173) |
贫血 | 1.837 | 0.127 | 207.942 | <0.001 | 6.276(4.889~8.055) |
低HDL-C血症 | 0.547 | 0.140 | 15.299 | <0.001 | 1.728(1.314~2.272) |
蛋白尿 | 0.765 | 0.103 | 54.867 | <0.001 | 2.149(1.755~2.632) |
70~79岁 | 1.062 | 0.112 | 90.237 | <0.001 | 2.891(2.323~3.600) |
80~89岁 | 2.069 | 0.126 | 269.989 | <0.001 | 7.915(6.184~10.131) |
≥90岁 | 2.847 | 0.198 | 205.870 | <0.001 | 17.239(11.684~25.434) |
Table 4 Multivariate Logistic regression analysis of influencing factors of renal dysfunction
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
高血压 | 1.212 | 0.120 | 102.277 | <0.001 | 3.361(2.657~4.251) |
糖尿病 | 1.423 | 0.088 | 264.184 | <0.001 | 4.151(3.496~4.28) |
高TG血症 | 0.560 | 0.110 | 25.754 | <0.001 | 1.751(1.410~2.173) |
贫血 | 1.837 | 0.127 | 207.942 | <0.001 | 6.276(4.889~8.055) |
低HDL-C血症 | 0.547 | 0.140 | 15.299 | <0.001 | 1.728(1.314~2.272) |
蛋白尿 | 0.765 | 0.103 | 54.867 | <0.001 | 2.149(1.755~2.632) |
70~79岁 | 1.062 | 0.112 | 90.237 | <0.001 | 2.891(2.323~3.600) |
80~89岁 | 2.069 | 0.126 | 269.989 | <0.001 | 7.915(6.184~10.131) |
≥90岁 | 2.847 | 0.198 | 205.870 | <0.001 | 17.239(11.684~25.434) |
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
糖尿病 | 0.227 | 0.061 | 13.748 | <0.001 | 1.255(1.113~1.415) |
男性 | 0.179 | 0.058 | 9.713 | 0.002 | 1.197(1.069~1.339) |
肥胖 | 0.238 | 0.066 | 12.906 | <0.001 | 1.269(1.114~1.445) |
高TG血症 | 0.178 | 0.073 | 5.952 | 0.015 | 1.194(1.036~1.378) |
Scr | 0.005 | 0.001 | 11.054 | 0.001 | 1.005(1.002~1.007) |
BUN | 0.006 | 0.016 | 13.517 | <0.001 | 1.062(1.029~1.097) |
Table 5 Multivariate Logistic regression analysis of influencing factors of proteinuria
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
糖尿病 | 0.227 | 0.061 | 13.748 | <0.001 | 1.255(1.113~1.415) |
男性 | 0.179 | 0.058 | 9.713 | 0.002 | 1.197(1.069~1.339) |
肥胖 | 0.238 | 0.066 | 12.906 | <0.001 | 1.269(1.114~1.445) |
高TG血症 | 0.178 | 0.073 | 5.952 | 0.015 | 1.194(1.036~1.378) |
Scr | 0.005 | 0.001 | 11.054 | 0.001 | 1.005(1.002~1.007) |
BUN | 0.006 | 0.016 | 13.517 | <0.001 | 1.062(1.029~1.097) |
[1] |
|
[2] |
|
[3] |
|
[4] |
王善志,朱永俊,唐文庄,等. 中国成人及老年人群慢性肾脏病患病率Meta分析[J]. 中国老年学杂志,2017,37(21):5384-5388. DOI:10.3969/j.issn.1005-9202.2017.21.076.
|
[5] |
葛均波,徐永健. 内科学[M]. 8版. 北京:人民卫生出版社,2013.
|
[6] |
|
[7] |
孙治平,武晓春,戴瑛,等. 尿微量白蛋白/肌酐在老年健康体检人群慢性肾脏病筛查中的应用[J]. 实用老年医学,2021,35(3):278-281. DOI:10.3969/j.issn.1003-9198.2021.03.017.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
陈建峰,李莹. 上海市浦东城乡老年人估算肾小球滤过率及危险因素分析[J]. 中华全科医学,2017,15(5):823-826. DOI:10.16766/j.cnki.issn.1674-4152.2017.05.029.
|
[12] |
黄燕萍,茹倩影,张旦欢,等. 2012—2016年上海市长宁区老年人群慢性肾脏病患病率调查研究[J]. 中国全科医学,2020,23(17):2215-2218. DOI:10.12114/j.issn.1007-9572.2019.00.566.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
陈金玲,陈志晓,黎莉,等. 肾病诊治中尿微量白蛋白与尿肌酐比值测定的临床意义[J]. 中国实用医药,2019,14(23):49-50. DOI:10.14163/j.cnki.11-5547/r.2019.23.023.
|
[19] |
陈学东,潘灏. 慢性肾脏病随机尿、晨尿微量白蛋白肌酐比值与24h尿白蛋白的相关性分析[J]. 医学理论与实践,2021,34(5):732-734,757. DOI:10.19381/j.issn.1001-7585.2021.05.004.
|
[20] |
温远生,何志良,贺靖. 血清胱抑素C与尿微量白蛋白/肌酐比值联合检测在糖尿病早期肾损伤中的诊断价值分析[J]. 世界最新医学信息文摘,2021,21(75):477-478. DOI:10.3969/j.issn.1671-3141.2021.75.232.
|
[1] | ZHANG Zhao, ZHENG Tingting, WANG Yushu, LUO Fei, LIU Lei. Analysis of the Current Status and Influencing Factors of Self-management in Patients with Degenerative Spinal Deformity [J]. Chinese General Practice, 2024, 27(15): 1867-1872. |
[2] | GAO Ying, XU Xinyi, LIU Yang, YANG Xiaokun. Research on the Development of Atherosclerotic Cardiovascular Disease Prediction Model for the Elderly Based on TCM Constitution [J]. Chinese General Practice, 2024, 27(15): 1878-1885. |
[3] | WU Meiqian, XIAO Jin, LI Feifei, HU Rongrong, LIU Caixia. 24-hour Movement Behaviors: a New Direction for the Study of Factors Affecting Health of the Elderly [J]. Chinese General Practice, 2024, 27(15): 1911-1916. |
[4] | ZHONG Ailin, LIU Ailing, ZHOU Shangcheng, GAO Sande, GAO Jing, ZOU Guanyang, CHEN Yingyao. Analysis of Knowledge-attitude-practice Behavior and Influencing Factors for Prevention of Disease in TCM in Community Residents in Guangzhou [J]. Chinese General Practice, 2024, 27(15): 1886-1892. |
[5] | ZHAO Hongbo, WU Xiaojing, YANG Yun, GE Zhiming, FAN Xianxian, ZHAO Lan, WANG Hongwei. Analysis of the Efficacy of Tiaozhong Yiqi Soup on Elderly Qi Deficiency Type Slow Transit Constipation [J]. Chinese General Practice, 2024, 27(12): 1487-1492. |
[6] | JIN Menglong, QIN Xiaoying, MALIYA Amiti, JIAZINI Nuerbai, LI Jianxin, CAO Jie, LUO Sifu, LIU Cheng, ZHANG Yuchen, GAI Mintao, LI Yanpeng, LU Xiangfeng, FU Zhenyan. Status and Influencing Factors of Dyslipidemia, Hypertension and Diabetes Comorbidities among Kazakhs in Xinjiang [J]. Chinese General Practice, 2024, 27(12): 1438-1444. |
[7] | LIU Ying, JIANG Juncheng, JING Huiquan. Correlation of Regional Differences in the Prevalence and Types of Chronic Diseases among Middle-aged and Elderly People with Health Resources Allocation in China [J]. Chinese General Practice, 2024, 27(12): 1452-1459. |
[8] | SHANG Jinmeng, DENG Xiaowei. Characteristics and Risk Factors of Preserved Ratio Impaired Spirometry in Physical Examination Population [J]. Chinese General Practice, 2024, 27(11): 1331-1336. |
[9] | XU Li, GE Jing, YU Peng, YU Ying. Shifts in Chronic Disease and Comorbidity Patterns among Chinese Older Adults: an Analysis Based on the China Health and Retirement Longitudinal Study [J]. Chinese General Practice, 2024, 27(11): 1296-1302. |
[10] | XIE Yi, XU Junma, XU Fangqin, LI Chao, CHEN Chen, SHAO Chan. Predictive Value of Sarcopenia Index for Prognosis in Elderly Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2024, 27(11): 1326-1330. |
[11] | WANG Wenjuan, WANG Rui, ZENG Hongji, LIU Yahui, WEI Shufan, TIAN Qingfeng. Relationship between Serum Liver Transaminase and Metabolic Syndrome in the Aged Based on Restrictive Cubic Spline Model [J]. Chinese General Practice, 2024, 27(11): 1337-1342. |
[12] | SHI Yushuang, WANG Huihua, LI Yan, LU Ping, SONG Wei, PAN Guijun. Analysis of the Effectiveness of Different Atrial Fibrillation Screening Methods in the Community-based Elderly Population [J]. Chinese General Practice, 2024, 27(11): 1316-1319. |
[13] | KANG Jing, ZHANG Ci, ZHANG Zhengyi. Distribution and Influencing Factors of Chronic Comorbidities among Middle-aged Inpatients in General Practice Department of Tertiary General Hospitals [J]. Chinese General Practice, 2024, 27(11): 1310-1315. |
[14] | HE Haiyang, YANG Jialing, LEI Xun. Prevalence and Influencing Factors of Osteoporosis in Postmenopausal Women: a Meta-analysis [J]. Chinese General Practice, 2024, 27(11): 1370-1379. |
[15] | YU Xinyan, SU Peng, YUAN Xiaojing, JIANG Qingru, YANG Jianyun, ZHAO Xudong, WANG Yifan, ZHANG Haicheng. A Study on the Factors Influencing the Comprehensive Risk of Cardiovascular Disease in Elderly Patients with Chronic Disease in Primary Care [J]. Chinese General Practice, 2024, 27(10): 1186-1193. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 874
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 721
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||